Clinical ResearchDurability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation
This paper was presented in part at the 2018 Annual Meeting of the American Heart Association on November, 10-14, 2018, in Chicago, Illinois.
Under an Elsevier user license
open archive
Central Illustration
Key Words
left ventricular assist device
right heart failure
tricuspid valve repair
Abbreviations and Acronyms
LVAD
left ventricular assist device
RHF
right heart failure
RV
right ventricle
RVAD
right ventricular assist device
TAPSE
tricuspid annulus plane systolic excursion
TR
tricuspid regurgitation
TV
tricuspid valve
TVr
tricuspid valve repair
Cited by (0)
Supported by U.S. National Heart, Lung, and Blood Institute grant 1R38HL143612-01 (to Dr. Bishawi). Drs. Milano and Bishawi have received research support from Abbott and Medtronic. Dr. Daneshmand serves on the medical advisory board of Fresenius. Dr. Nicoara is a consultant for Abbott. Dr. Velazquez has received research support from and is a consultant for Novartis. Dr. Patel is a consultant for Abbott Labs. Dr. Milano is a consultant for Abbott Labs and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. John Teerlink, MD, served as Guest Editor for this paper.
- ∗
Drs. Barac and Nicoara contributed equally to this work.
© 2020 the American College of Cardiology Foundation. Published by Elsevier.